SEC Form 4 · accession 0001140361-16-066567
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
John Niederhuber
Director
Period of report
May 18, 2016
Accepted (ET)
May 20, 2016 · 6:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 18, 2016 | D | 7,833 | $0.00 | D | 22,467 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of unvested restricted stock units forfeited due to resignation.
- F2The total number of shares has been reduced by 7,833 as a result of the Reporting Person's resignation from the Emergent Board of Directors in connection with his being named as prospective Director of Aptevo, an entity being spun-off from Emergent.